All stock lists
Invivyd, Inc. (NASDAQ:IVVD)
US · Delayed Price · Currency is USD
Also listed: ADGIHealthcare · Biotechnology
0.61-0.01 (-1.17%)
Insider Score
––Not scored
IVVD Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
IVVD Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 14.29 M | 13.74 M | 17.21 M | 13.13 M | 11.79 M | 11.30 M |
| Revenue Growth (YoY) | 21.20 % | 21.59 % | 24.51 % | 41.17 % | 420.58 % | — |
| Cost of Revenue | 1.27 M | 1.54 M | 1.14 M | 1.09 M | 685.00 K | 834.00 K |
| Gross Profit | 13.01 M | 12.20 M | 16.07 M | 12.04 M | 11.10 M | 10.47 M |
| SG&A Expense | 29.46 M | 24.60 M | 18.57 M | 15.02 M | 16.59 M | 16.75 M |
| R&D Expense | 29.37 M | 30.73 M | 10.05 M | 8.05 M | 9.57 M | 10.64 M |
| Operating Expenses | 58.83 M | 55.34 M | 28.62 M | 23.06 M | 26.16 M | 27.39 M |
| Operating Income | -45.82 M | -43.14 M | -12.55 M | -11.02 M | -15.06 M | -16.92 M |
| Pretax Income | -44.39 M | -41.40 M | -11.07 M | -10.47 M | -14.66 M | -16.29 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -44.39 M | -41.40 M | -11.07 M | -10.47 M | -14.66 M | -16.29 M |
| EPS (Basic) | -0.14 | -0.13 | -0.06 | -0.06 | -0.12 | -0.14 |
| EPS (Diluted) | -0.14 | -0.13 | -0.06 | -0.06 | -0.12 | -0.14 |
| Shares Outstanding | 320.44 M | 309.67 M | 172.21 M | 170.17 M | 120.02 M | 119.88 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.